AMGEN (AMGN) P/E (2008 - 2026)
AMGEN (AMGN) P/E from Jun 30, 2008 to Jul 21, 2026. The TTM AMGEN (AMGN) P/E is 25.30. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of AMGEN (AMGN)
| Year | P/E | Change |
|---|---|---|
| 2026 | 25.30 | +10.71% |
| 2025 | 22.85 | -33.27% |
| 2024 | 34.25 | +68.30% |
| 2023 | 20.35 | -2.04% |
| 2022 | 20.77 | -3.86% |
| 2021 | 21.61 | +16.86% |
| 2020 | 18.49 | +0.03% |
| 2019 | 18.48 | +22.80% |
| 2018 | 15.05 | -3.40% |
| 2017 | 15.58 | +7.87% |
| 2016 | 14.45 | -18.42% |
| 2015 | 17.71 | -24.49% |
| 2014 | 23.45 | -71.82% |
| 2013 | 83.23 | +445.03% |
| 2012 | 15.27 | -2.85% |
| 2011 | 15.72 | +39.08% |
| 2010 | 11.30 | -9.63% |
| 2009 | 12.51 | -60.70% |
| 2008 | 31.82 | N/A |
Comparison AMGEN (AMGN) P/E with competitors
AMGEN (AMGN) P/E is 25.30.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| GRFS | Grifols SA | 10.11 | -60.04% |
| PFE | Pfizer Inc | 11.65 | -53.93% |
| NVO | Novo Nordisk | 11.79 | -53.39% |
| GSK | GSK Plc | 12.10 | -52.16% |
| SNY | Sanofi | 12.12 | -52.07% |
| BMY | Bristol-Myers Squibb Company | 13.82 | -45.37% |
| OGN | Organon & Company | 14.33 | -43.37% |
| BIIB | Biogen Inc | 17.41 | -31.20% |
| GILD | Gilead Sciences Inc | 17.75 | -29.86% |
| NVS | Novartis AG | 21.60 | -14.63% |
| JNJ | Johnson & Johnson | 22.09 | -12.69% |
| MRK | Merck & Co Inc | 26.93 | +6.44% |
| AZN | Astrazeneca plc | 28.44 | +12.43% |
| LLY | Lilly(Eli) & Company | 48.44 | +91.49% |
| ABBV | Abbvie Inc | 139.08 | +449.77% |